FDA Clears PanopticAI's Contactless Respiratory Rate Measurement
Following the startup's first FDA 510 (k) clearance for its contactless pulse rate monitoring, PanopticAI has now secured a second one for respiratory rate measurement. This milestone cements its position as the world leader in camera-based...
FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial
Highlights: FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol This marks the official entry of NUZ-001 as Regimen I in the HEALEY ALS Platform Trial Next steps include obtaining single...